wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q49984769-2023C860-A21C-464B-AD7E-7833ECB85495
Q49984769-2023C860-A21C-464B-AD7E-7833ECB85495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49984769-2023C860-A21C-464B-AD7E-7833ECB85495
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
P2860
Q49984769-2023C860-A21C-464B-AD7E-7833ECB85495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49984769-2023C860-A21C-464B-AD7E-7833ECB85495
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ff6d0e131bf0bf6d19d323e064bd46bbe516783
P2860
Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.